Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CSE Bulletin: INDEX - CSE 25 INDEX QUARTERLY REBALANCING

C.EPIC, C.MMAX, V.LIFT, C.CYBT

Toronto, Ontario--(Newsfile Corp. - Le 14 décembre 2022/December 2022) - The quarterly rebalancing of the CSE 25 Index will result in the following changes, effective after the close on Friday, December 16, 2022.

Le rééquilibrage trimestriel de l’indice composé du CSE 25 entraînera les modifications suivantes, en vigueur à la fermeture le vendredi 16 décembre 2022.

ADDITIONS

Symbol Issuer Sector
CMND Clearmind Medicine Inc. Life Sciences
CYBT Cybeats Technologies Corp. Technology
EPIC 1CM Inc Life Sciences
LIFT Li-FT Power Ltd. Mining
MMAX Metamaterial Exchangeco Inc Technology
TCF Trillion Energy International Inc. Oil and Gas

DELETIONS

Symbol Issuer Sector
GDNS Goodness Growth Holdings Inc. Life Sciences
HEAT Hillcrest Energy Technologies Ltd. Technology
PBIT POSaBIT Systems Corporation Technology
PKK Tenet Fintech Group Inc Technology
RVV Revive Therapeutics Ltd. Life Sciences

Deletions from CSE 25 do not necessarily mean a deletion from the Composite.

Les suppressions de CSE 25 ne signifient pas nécessairement une suppression du composite.


For more information about the CSE 25 Index, including the full list of securities and the index methodology, visit the CSE website.

Pour plus d’information sur l’indice composé du CSE 25, incluant la liste complète des titres et la méthodologie indicielle, rendez-vous sur le site Web du CSE.

Contact Information/Coordonnées

Index Management/Gestion de l’indice :
Robert Cook
Senior Vice-President Market Development/Vice-président principal du développement
Robert.Cook@thecse.com (416) 367-7349

Media Relations/Relations avec la presse:
Richard Carleton, CEO
Richard.Carleton@thecse.com (416) 367-7360